Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall

There is ongoing research on how to reduce the undesired effects of population-based mammography screening, such as overdiagnosis and overtreatment [1]. Researchers seek to identify groups of women who are at low or high risk of developing breast cancer and who could benefit from tailored screening recommendations. Women with a false-positive recall (FPR) at screening (a recall caused by an anomaly found on screening mammography that finally excludes malignancy) are at increased risk of breast cancer diagnosis [2 –5].

Source: Maturitas - November 4, 2020 Category: Primary Care Authors: Maria Vernet-Tom ás, Javier Louro, Marta Román, Francina Saladié, Margarita Posso, Miguel Prieto, Ivonne Vázquez, Marisa Baré, Lupe Peñalva, Carmen Vidal, Xavier Bargalló, Mar Sánchez, Joana Ferrer, Josep A Espinàs, M Jesús Quintana, Ana Rodríg Source Type: research